Journal of Obstetrics and Gynaecology Research最新文献

{"title":"Situation of sexual and reproductive health and rights in Japan in comparison with the world","authors":"Hiromi Obara,&nbsp;Rei Haruyama,&nbsp;Sumiyo Okawa","doi":"10.1111/jog.16273","DOIUrl":"https://doi.org/10.1111/jog.16273","url":null,"abstract":"<p>Since the 1994 Cairo Conference, global efforts have focused on improving sexual and reproductive health and rights. This review examined the progress and challenges of the SRHR in Japan, comparing it with the global situation. SRHR indicators and situations were assessed using the United Nations Sustainable Development Goals' monitoring indicators and relevant reports. For the past two decades, Japan has consistently maintained the lowest maternal and neonatal mortality rates, as well as adolescent birth rates, globally. However, contraception-related indicators remain suboptimal and inadequately monitored at the national level. Although the percentage of unwanted pregnancies has decreased over time, unintended and unwanted pregnancies remain prevalent in Japan. Notably, adolescents (aged &lt;20 years) and youth (aged 20–24 years) accounted for over 33% of the total 126 734 induced abortions in 2023. The number of induced abortions among adolescents has consistently exceeded the number of live births in the same age group since the mid-1970s. In conclusion, key areas for further improvement in Japan include reducing unintended and unwanted pregnancies, improving contraception access and monitoring systems, and ensuring women's right to self-determination. As outlined by the Programme of Action of the Cairo Conference, appropriate information and means should be provided to support women and men, including adolescents and youths appropriately, in making informed decisions about their fertility. In collaboration with various health professionals and other sectors, obstetricians and gynecologists are expected to be more actively committed to improving SRHR in Japan and the world.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 4","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143717405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of ubiquinol intake on improving menstrual symptoms among female healthcare workers: An open-label pilot study","authors":"Tetsu Kinoshita,&nbsp;Koutatsu Maruyama,&nbsp;Kikumi Katakami,&nbsp;Takayo Sakiyama","doi":"10.1111/jog.16279","DOIUrl":"https://doi.org/10.1111/jog.16279","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This study aimed to investigate the effects of ubiquinol on menstrual symptoms.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This open-label trial involved 86 female healthcare workers aged 21–48 years. The study design included an observation period and a ubiquinol intake period. During the intake period, the participants consumed two soft capsules containing 75 mg of ubiquinol daily (i.e., 150 mg/day). At baseline and after the observation and intake periods, the participants underwent blood testing and completed the Pittsburgh Sleep Quality Index to evaluate their sleep condition. In addition, the Menstrual Distress Questionnaire was completed before, during, and after each of the first seven menses. All statistical analyses were performed, stratified by the median age of the participants.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Regarding the Menstrual Distress Questionnaire, in the younger group (age: &lt;36 years), a significant improvement was observed in menstrual “Control” (<i>p</i> = 0.049) by ubiquinol intake. In the older group (age: ≥36), the effects of ubiquinol on the improvement of premenstrual “Negative affect” and “Control” scores reached significance (<i>p</i> = 0.02 and <i>p</i> &lt; 0.01, respectively); further, menstrual “Control” score was significantly improved (<i>p</i> = 0.03). In addition, the Pittsburgh Sleep Quality Index showed a significant effect of ubiquinol in the older group.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This pilot study indicated that ubiquinol alleviated menstrual symptoms among premenopausal female healthcare workers. In those aged ≥36 years, ubiquinol intake may reduce premenstrual irritability and improve sleep quality.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 4","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143717233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The application value of routine office hysteroscopy prior in patients with one embryo transferred failure and normal transvaginal ultrasound","authors":"Hui-Juan Guan,&nbsp;Huai-Yun Tang,&nbsp;Hui Li,&nbsp;Jia-Hui Zhao,&nbsp;Jia Song,&nbsp;Li-Sha Tang","doi":"10.1111/jog.16267","DOIUrl":"https://doi.org/10.1111/jog.16267","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>The aim of our study was to investigate whether outpatient hysteroscopy performed in the month before starting an embryo transfer cycle in women who had experienced one failed in vitro fertilization treatment cycle could improve the treatment outcome.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This retrospective analysis selected the patients who were failures after the first embryo transfer of good-quality embryos between January 2019 to February 2023; the women did not undergo hysteroscopy before IVF, and ultrasound did not observe the pathological abnormalities. A total of 199 patients were included for analysis, 119 females in the hysteroscopic group and 80 females in the controlled group. Women in the study group underwent hysteroscopic examination 3–7 days of the clean menstrual period.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There was no statistically significant difference between the groups for demographic features and hysteroscopy cycle characteristics. The logistic regression analysis showed that performing hysteroscopy prior to patients who had one embryo transferred failure and normal transvaginal scan findings was not an influencing factor for live birth rate.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Performing diagnostic hysteroscopy in patients who had one embryo transfer failure and normal transvaginal scan findings did not improve fertility outcomes. Hence, routine usage of hysteroscopy should not be offered to patients who had one embryo transfer failure and without previously detected pathology of the uterine cavity.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 4","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143717234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Can fetal ultrasound predict adrenal hypoplasia congenita caused by Xp21 deletion?","authors":"Yuko Yokohama,&nbsp;Yoshio Makita,&nbsp;Yuriko Oishi,&nbsp;Ken Nagaya,&nbsp;Shigeru Suzuki,&nbsp;Yasuhito Kato","doi":"10.1111/jog.16276","DOIUrl":"https://doi.org/10.1111/jog.16276","url":null,"abstract":"<p>Xp21 deletion is a contiguous gene deletion syndrome characterized by adrenal hypoplasia congenita (AHC). If prenatal genetic diagnosis does not determine whether a male fetus at risk is affected, it is necessary to monitor him to diagnose adrenal insufficiency in the first few days of life to avoid a salt-losing adrenal crisis. Whether AHC can be diagnosed by prenatal ultrasound is not known. Ultrasound findings of fetal adrenal glands were compared between healthy and affected siblings whose mother was a carrier of the Xp21 deletion. The couple did not want an invasive prenatal diagnosis during either pregnancy. The adrenal glands of a healthy fetus have a two-layered structure, but this structure could not be confirmed in the affected male. We believe this is an important finding that suggests that steroid supplementation may be necessary immediately after birth.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 4","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143717404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Expectant management for women with intrauterine fetal death during the mid-trimester of pregnancy that was complicated by placenta previa","authors":"Kayo Lee,&nbsp;Kohei Ogawa,&nbsp;Hiromitsu Azuma,&nbsp;Akihiko Sekizawa,&nbsp;Seiji Wada","doi":"10.1111/jog.16275","DOIUrl":"https://doi.org/10.1111/jog.16275","url":null,"abstract":"<p>After the mid-second trimester, women with intrauterine fetal death (IUFD) are managed with cervical dilation and vaginal gemeprost or intravenous oxytocin. In women with IUFD complicated by placenta previa, unneglectable concerns about massive bleeding during the procedure pose a burden on healthcare providers. Although a standardized management remains unestablished, the treatment options for IUFD complicated by placenta previa include cesarean section, gemeprost, and intravenous oxytocin, and such procedures follow uterine artery embolization. However, these strategies have non-negligible risks, such as bleeding during the procedure and adverse effects on future pregnancies. Herein, we present a case of a woman with IUFD at 24 weeks of gestation and complete placenta previa, who delivered a baby with a low blood loss volume after 40 days of expectant management, potentially attributed to placental migration and reduced placental blood flow volume.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 4","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143717231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Initiatives for Promoting Patient Safety in Obstetric Care Starting from Advanced Life Support in Obstetrics (ALSO™) in Japan","authors":"Takanari Arai","doi":"10.1111/jog.16239","DOIUrl":"https://doi.org/10.1111/jog.16239","url":null,"abstract":"<p>The simulation course in obstetric emergencies aims not only to improve knowledge and skills but also to enhance team approaches and patient safety. Particularly for enhancing team approaches and patient safety, it is effective for team members, regardless of their professional roles, to come together to share learning opportunities that can be applied to real clinical practice. The concept of “To Err is Human,” acknowledging the inherent limitations of human performance, underscores the importance of patient safety and has driven the adoption of interdisciplinary approaches to mitigate these limitations, establishing patient safety as a critical academic field. Advanced Life Support in Obstetrics (ALSO) has swiftly adopted this concept, providing essential simulation-based training to strengthen medical teams dedicated to ensuring safe childbirth. The ALSO provider certification signifies that an individual has successfully completed a comprehensive educational program qualifying them not only as “a specialist with the requisite knowledge and skills in obstetric care” but also as “a member of a collective of specialists capable of providing safe maternal and child healthcare.” The dissemination of simulation-based education, such as ALSO and BLSO, along with the related continuous medical education focused on training obstetricians and midwives as instructors, is an important initiative for “distribution of healthcare” through Japan's education in patient safety.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 3","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jog.16239","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143717232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ectopic pregnancy after hysterectomy study: A systematic review of published case reports comparing ectopic pregnancy following total and supracervical hysterectomy","authors":"Awoniyi Awonuga,&nbsp;Solomon Agboroko,&nbsp;Daniel Moussa,&nbsp;Richard Hsu,&nbsp;Megan Fee,&nbsp;Jeenal Shah,&nbsp;Sakshi Das,&nbsp;Chinyere Nnaji,&nbsp;Olivia G. Camp,&nbsp;Michael Diamond","doi":"10.1111/jog.16268","DOIUrl":"https://doi.org/10.1111/jog.16268","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>To perform a systematic review of all published case reports and compare ectopic pregnancy following total versus supracervical hysterectomy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Published case reports of patients with ectopic pregnancy following hysterectomy up to July 12, 2024, were searched using PubMed, Google Scholar, Embase, Scopus, and Web of Science databases using the terms “post-hysterectomy ectopic pregnancy,” OR “pregnancy after hysterectomy.” Manuscripts with case reports of ectopic pregnancy following previous hysterectomy were statistically analyzed. Categorical variables were analyzed using the chi-squared or Fisher's exact test and continuous variables by independent <i>t</i>-test and Wilcoxon rank sum test. A <i>p</i>-value &lt;0.05 determined statistical significance.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Results</h3>\u0000 \u0000 <p>One hundred and eight cases reported by 106 authors were eligible for analysis. Of these, 34 underwent supracervical and 74 total hysterectomies. There were no differences between the two groups in the demographic variables, symptoms, and status of patients at presentation. Patients with a history of supracervical, unlike total hysterectomy, were less likely to have their pregnancy associated with the period just before or shortly after hysterectomy (termed the peri-hysterectomy period) (OR 0.18, 95% CI [0.06–0.54], <i>p</i> &lt; 0.001). However, they are more likely to have a diagnosis of possible ectopic pregnancy before surgery (OR 3.56, 95% CI [1.45–8.73], <i>p</i> = 0.007).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Physicians should be aware that ectopic pregnancy following a supracervical, unlike total hysterectomy, occurs more often remote from the peri-hysterectomy period and should include ectopic pregnancy in their differential diagnosis of abdominal and pelvic pain in all previously hysterectomized patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 4","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143717400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Influence of equol production capacity on female lower urinary tract symptoms","authors":"Chie Nakagawa,&nbsp;Yoshiyuki Okada,&nbsp;Miwa Shigeta,&nbsp;Yukiko Nomura,&nbsp;Akihiko Sekizawa,&nbsp;Yasukuni Yoshimura","doi":"10.1111/jog.16266","DOIUrl":"https://doi.org/10.1111/jog.16266","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>We aimed to investigate the relationship between lower urinary tract symptoms in females and their equol production capacity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In this cross-sectional study, the production capacity of equol in Japanese women (aged 20–75 years), with (group L, <i>n</i> = 95) and without (group C, <i>n</i> = 122) lower urinary tract symptoms, was examined. Equol production was determined by measuring the concentration of urinary equol by immunochromatography. Equol production was defined as a urinary equol concentration of 1.0 μM or more. The presence of lower urinary tract symptoms was determined using three questionnaires that evaluated lower urinary tract symptoms.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The proportions of equol production in groups L and C were 28.4% and 52.5%, respectively (<i>p</i> = 0.0004). Multivariate analysis (logistic regression analysis) showed that the inability to produce equol was a significant risk factor for lower urinary tract symptoms (odds ratio, 2.21; <i>p</i> = 0.0144).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This study revealed that equol production capacity may be associated with lower urinary tract symptoms. Further research, including interventional studies, is required for verification. Additionally, because lower urinary tract symptoms include a variety of symptoms, the association between each symptom and equol production capacity needs to be investigated.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 3","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of mid-term abdominal pregnancy: A rare case report and literature review","authors":"Junlei Lu,&nbsp;Hongkai Shang,&nbsp;Jing Qian","doi":"10.1111/jog.16277","DOIUrl":"https://doi.org/10.1111/jog.16277","url":null,"abstract":"<p>Abdominal pregnancy (AP) is a rare form of ectopic pregnancy. It is associated with significant maternal and fetal risks, including high rates of morbidity and mortality. The condition poses considerable therapeutic challenges, particularly in the mid to late stages of gestation. To date, there is no standardized treatment protocol for such cases. We describe a case of a 37-year-old woman, G2P1, who was diagnosed with a live 16-week AP. The patient underwent multidisciplinary treatment, including ultrasound-guided methotrexate injection into the fetal heart, lauromacrogol injection into the placenta, oral administration of mifepristone, and subsequent laparotomy to remove the fetus, placenta, and left fallopian tube. This approach successfully demised the fetus, reduced the placental blood supply, and created more favorable conditions for surgery. The patient recovered uneventfully post-surgery. This case illustrates the potential benefits of a combined therapeutic approach in successfully managing mid-term AP.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 3","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143689932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of serum inflammatory markers in determining the severity of cervical lesions","authors":"Ufuk Atlıhan,&nbsp;Onur Yavuz,&nbsp;Burak Ersak,&nbsp;Can Ata,&nbsp;Tevfik Berk Bildacı,&nbsp;Selcuk Erkilinc,&nbsp;Huseyin Aytug Avsar,&nbsp;Ali Cenk Özay,&nbsp;Ulas Solmaz","doi":"10.1111/jog.16278","DOIUrl":"https://doi.org/10.1111/jog.16278","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To evaluate the role of serum inflammatory markers in determining colposcopy indications more accurately, reducing unnecessary colposcopy requests, and preventing overtreatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>In our study, the data of 218 patients who were followed up in our hospital's oncology outpatient clinic between April 2017 and November 2023 and who underwent colposcopy and biopsy for suspected cervical lesions due to Papanicolaou smear test abnormalities or the presence of human papillomavirus were evaluated retrospectively. The parameters of patients with and without cervical lesions were compared. Patients with cervical lesions were compared according to lesion type.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio levels were significantly higher in the cervical lesions (+) group compared with the cervical lesions (−) (<i>p</i> &lt; 0.001 and <i>p</i> &lt; 0.001, respectively). Systemic immuno-inflammation index and systemic inflammatory response index levels were significantly higher in the cervical lesions (+) group compared with the cervical lesions (−) group (<i>p</i> &lt; 0.001 and <i>p</i> &lt; 0.001, respectively). Mean platelet volume level was significantly lower in the cervical lesions (+) group compared with the cervical lesions (−) group (<i>p</i> &lt; 0.001). In the group with cervical lesions, no significant relationship was found between the severity of the cervical lesions and serum inflammatory marker levels.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>According to the results of our study, although there were significant differences between the serum inflammatory marker levels of patients with and without cervical lesions, their importance in predicting cervical lesions could not be clearly demonstrated. The importance of serum inflammatory markers should be evaluated in prospective studies with larger patient numbers and longer follow-up periods.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 3","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143689931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}